Emeramide

N/A

Report date: 2023/03/05 16:37:23
NME

Base Information

Drug NameEmeramide
Drug Alias Name依美拉胺emeramidum赛密拉米德NBMI艾美酰胺 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChelating agentsAnti-oxidative stress
TargetsNot applicable
Therapy Area/IndicationsMercury Poisoningbeta-ThalassemiaSupranuclear Palsy, Progressive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySloveniaAlbaniaEcuador +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A

Develop Information

Active CompaniesEmeramed Ltd
Inactive CompaniesNbmi Science Ab
Active IndicationsMercury PoisoningSupranuclear Palsy, ProgressiveMultiple System Atrophy
Inactive Indicationsbeta-ThalassemiaPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A